期刊文献+

胃镜活检与外科病理诊断胃癌临床对比分析 被引量:8

胃镜活检与外科病理诊断胃癌临床对比分析
暂未订购
导出
摘要 目的:分析并探讨胃镜活检与外科病理诊断胃癌临床结果差异。方法:回顾性分析收治胃镜诊断为胃癌患者132例临床诊治资料。结果:本组患者胃镜活检与外科病理诊断胃癌阳性例数符合率为90.9%;患者中胃镜活检溃疡型所占比例明显高于隆起型与平坦型,组间比较差异有统计学意义(P<0.05);胃镜活检和外科病理诊断为分化型胃癌诊断符合率为94.4%;而分化不良型胃癌诊断符合率仅为54.8%。结论:胃镜活检用于胃癌诊断具有重要应用价值,但是对于低分化型胃癌诊断误差仍然较大,需要引起注意。 Objective:To analysis and investigate the differences of diagnosis results of gastric cancer from endoscopic biospy and surgical pathology. Methods:The clinical data of 132 patients with gastric cancer were analyzed retrospectively in the period from March 2008 to May 2010 in our hospital. Results:The compliance rate is 90. 9% of positive cases of endoscopic biospy diagnosis with surgical pathology diagnosis in this study. The percentage of ulcer type were significantly higher than elevated type and fiat type(P 〈0. 05). The compliance rate is 94.4% of positive cases with differentiated gastric cancer of endoscopic biospy diagnosis with surgical pathology diagnosis, but the rate of positive cases with poorly differentiated gastric cancer is only 54.8%. Conclusion: The diagnosis of gastric cancer with endoscopic biospy possesses important complication values, but there are greater disgnostic errors of poorly differentiated type of gatrie cancer.
作者 韩金霞
出处 《中国社区医师(医学专业)》 2012年第8期245-245,247,共2页
关键词 胃镜活检 外科病理诊断 符合率 对比 Endoscopic biopsy Surgical pathology diagnosis Compliane rate Contrast
  • 相关文献

参考文献17

二级参考文献37

  • 1王筱斐,王颖.不同剂量瑞芬太尼联合异丙酚在无痛胃镜检查中对呼吸、循环系统的影响——附80例报告[J].新医学,2006,37(2):102-104. 被引量:12
  • 2黎清成,郑丰平.清醒镇静胃镜检查的临床效果和安全性研究──附560例报告[J].新医学,2007,38(4):236-237. 被引量:6
  • 3马兴刚 王昌成.379例胃癌内镜及病理检查结果分析[J].中华消化内镜杂志,1999,16:374-374.
  • 4ROTS W I, MOKOENA T. Successful endoscopic closure of a benign gastrocolonic fistula using human fibrin sealant through gastroscopic approach: a case report and review of the literature [ J ]. Eur J Gastroenterol Hepatol, 2003, 15 (13) : 1351-1356.
  • 5方野纯治.内镜诊断与鉴别诊断图谱[M].沈阳:辽宁科技出版社,2003:292.
  • 6Cadman B, DixonMF, Wyatt J 1. Value of routine, non - targeted bi2op sies in the diagnosis of gastric neop lasia [J]. J Clin Pathol, 1997, 50:852-834.
  • 7Sipponen P, StoheM. Clinical impact of routine biop sies of the gastficantrum and body [J]. Endoscopy, 2007, 29:671-678.
  • 8PlummerM, Buiatti E. Histological diagnosis of p recancerous lesions of the stomach: a reliability study [J]. Int J Ep idemiol, 2006, 26:716 -720.
  • 9GuoW, Zhang YL. Effect of the number of biop sy tissue and cytologi2cal smears on lesion diagnostic rate [ J ]. Xiandai Xiaohuabing J i Nei2jing Zazhi, 1996, 1 : 80 -81.
  • 10陈灏珠.内科学[M].北京:人民卫生出版社,1996.514-517.

共引文献459

同被引文献46

  • 1Hnfmann M, Stoss O, Shi D, et al. Assessment of a HER2 scoring system fi,r gastric cancer: results from a validation study[J]. Histopathology, 2008, 52 ( 7 ) : 797-805.
  • 2Van Culsem E, Kang Y, Chung H, et al.Effica,'y results from Lhe ToGA trial: a phase 111 study of trastuzumab added to slandard :hemotherapy ( CT ) in first-line human epidermal growth factor receptor 2 ( tIER2 ) -positive advanced gastric" eaneer ( GC )[J].AS- CO Meeting, 2009, 27 ( 18 ) : 509.
  • 3BangY J, Vam Custsem E, Feyereisolva A, elaI.Trastuzumah in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA) : a phase 2, open-label, randomized controlled trial[J].Lancet, 2010, 376 ( 9742 ) : 687-697.
  • 4Jorgensen J T.Targeled HER2 treatment in advaneed gastric cancer[J]. Ontology, 2010, 78 ( 1 ) : 26-33.
  • 5Vance G H, Barry T S, Bloom K J, et al.Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines[J].Arch PatholLabMed, 2009, 133 (4) : 611-612.
  • 6Tabit C E, Chung W B, Hamburg N M, et al.Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications[J].Rev Endocr Metab Disord, 2010, 11 ( 1 ) : 61-74.
  • 7Endemann D H, Schiffrin E L.Endothelial dysfunction[J].J Am Soc Nephrol, 2004, 15 (8) : 1983-1992.
  • 8lzzard A S, Rizzoni D, Agabiti-Rosei E, et al.Small artery structure and hypertension: adaptive changes and target organ damage[J].J Hypertens, 2005, 23 ( 2 ) : 247-250.
  • 9Tabit C E, Chung W B, Hamburg N M, et al.Endothelial dysfunction in diabetes mellitus., molecular mechanisms and clinical implications[J].Rev Endocr Metab Disord, 2010, 11 ( 1 ) : 61-74.
  • 10Nicolls M R, Haskins K, Flores S C.Oxidant stress, immune dysregulation, and vascular function in type Ⅱdiabetes[J].Antioxid Redox Signal, 2007, 9 ( 7 ) : 879-889.

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部